Physician

Brian M Slomovitz, M.D.

According to 2025 Medicare claims, Brian Slomovitz, M.D. (NPI: 1306885512) practices gynecologist/oncologist in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is PHYSICIAN PRACTICES OF MSMC, LLC (NPI: 1356630628; TIN: 451154796) and primary practice location at 33140-2800. Slomovitz is affiliated with the NeueHealth Collaborative Care LLC (ACO ID: A5513), participating under the MSSP model.

Slomovitz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 125 traditional Medicare patients, billed 478 HCPCS/CPT codes, and received $56,798 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 137 prescription claims across 58 beneficiaries totaling $216,431 in drug costs, led by Everolimus (Everolimus). DME data shows 39 claims. Open Payments data shows 240 records totaling $3,255,516. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $47,891 and ending at $56,798. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $27,057 and ending at $216,431. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	177	401	$47,891
2016	195	441	$49,406
2017	190	541	$51,592
2018	187	574	$57,369
2019	221	778	$70,688
2020	26	55	$9,915
2021	68	201	$28,671
2022	88	322	$47,882
2023	118	426	$53,401
2024	125	478	$56,798

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	51	137	$27,057
2016	60	166	$20,607
2017	55	177	$21,786
2018	48	106	$47,658
2019	81	257	$406,346
2020	20	44	$2,882
2021	44	117	$4,157
2022	60	113	$54,136
2023	75	233	$755,920
2024	58	137	$216,431

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	13	$444
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	39	$6,485

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	41	219	$117
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	27	27	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	64	105	$73

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Everolimus	Everolimus	15	446	$78,608
Premarin	Estrogens, Conjugated	13	948	$5,776
Letrozole	Letrozole	21	810	$308
Ibuprofen	Ibuprofen	20	146	$95

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	13	$4,029
B4224	Parenteral nutrition administration kit, per day	N	N/R	13	$1,861
B4220	Parenteral nutrition supply kit; premix, per day	N	N/R	13	$596

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	142	$93,446	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	98	$3,162,070	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian M. Slomovitz, M.D.?

Tedicare shows public-source Medicare data for Brian M. Slomovitz, M.D. (NPI 1306885512), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian M. Slomovitz, M.D. have ACO affiliation data?

Brian M. Slomovitz, M.D. is shown with ACO affiliation data for NeueHealth Collaborative Care LLC (MSSP, ACO ID A5513).

What billing organization is linked to Brian M. Slomovitz, M.D.?

Brian M. Slomovitz, M.D. is linked to PHYSICIAN PRACTICES OF MSMC, LLC (billing NPI 1356630628) in the available physician profile data.

Does Brian M. Slomovitz, M.D. have Open Payments data?

Brian M. Slomovitz, M.D. has 240 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.